SPRK1 INHIBITORS AND METHODS OF USE
Provided herein are compounds having a structure of Formula (I) and pharmaceutically acceptable salts thereof which can act as modulators of serine/arginine-rich splicing factor protein kinase- 1 (SRPK1). Further disclosed herein are methods for treating cancer and vascular diseases and disorders. L...
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English French |
| Published |
25.07.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Provided herein are compounds having a structure of Formula (I) and pharmaceutically acceptable salts thereof which can act as modulators of serine/arginine-rich splicing factor protein kinase- 1 (SRPK1). Further disclosed herein are methods for treating cancer and vascular diseases and disorders.
L'invention concerne des composés ayant une structure de formule (I) et des sels pharmaceutiquement acceptables de ceux-ci, qui peuvent agir en tant que modulateurs de la protéine kinase 1 du facteur d'épissage riche en sérine/arginine (SRPK1). L'invention concerne en outre des méthodes de traitement du cancer et de maladies et de troubles vasculaires. |
|---|---|
| AbstractList | Provided herein are compounds having a structure of Formula (I) and pharmaceutically acceptable salts thereof which can act as modulators of serine/arginine-rich splicing factor protein kinase- 1 (SRPK1). Further disclosed herein are methods for treating cancer and vascular diseases and disorders.
L'invention concerne des composés ayant une structure de formule (I) et des sels pharmaceutiquement acceptables de ceux-ci, qui peuvent agir en tant que modulateurs de la protéine kinase 1 du facteur d'épissage riche en sérine/arginine (SRPK1). L'invention concerne en outre des méthodes de traitement du cancer et de maladies et de troubles vasculaires. |
| Author | KUHN, Cyrille LI, Lianhai |
| Author_xml | – fullname: KUHN, Cyrille – fullname: LI, Lianhai |
| BookMark | eNrjYmDJy89L5WRQDg4I8jZU8PTz8HTyDPEPClZw9HNR8HUN8fB3CVbwd1MIDXblYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBkYmhqamFmYmjobGxKkCALg-JTc |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | INHIBITEURS DE SPRK1 ET PROCÉDÉS D'UTILISATION |
| ExternalDocumentID | WO2024155864A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_WO2024155864A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Aug 09 05:00:43 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_WO2024155864A13 |
| Notes | Application Number: WO2024US12097 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240725&DB=EPODOC&CC=WO&NR=2024155864A1 |
| ParticipantIDs | epo_espacenet_WO2024155864A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20240725 |
| PublicationDateYYYYMMDD | 2024-07-25 |
| PublicationDate_xml | – month: 07 year: 2024 text: 20240725 day: 25 |
| PublicationDecade | 2020 |
| PublicationYear | 2024 |
| RelatedCompanies | ALLIANTHERA BOSTON INC ALLIANTHERA (SUZHOU) BIOPHARMACEUTICAL CO., LTD |
| RelatedCompanies_xml | – name: ALLIANTHERA BOSTON INC – name: ALLIANTHERA (SUZHOU) BIOPHARMACEUTICAL CO., LTD |
| Score | 3.5515234 |
| Snippet | Provided herein are compounds having a structure of Formula (I) and pharmaceutically acceptable salts thereof which can act as modulators of... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | SPRK1 INHIBITORS AND METHODS OF USE |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240725&DB=EPODOC&locale=&CC=WO&NR=2024155864A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8BhT1Dedih9TApO-FdemzbqHIesXrdIP2k73NpoaQZA5XMW_7zV0uqeRl-QOLh9wuY_k7gDuBOXszTLHKrOoUI2xxlVUQ7haUWYNuc4oldUbopgFM-Nxbs478LGJhZF5Qn9kckTkqAr5vZb39erfieXKv5Xre_6OoM8Hv5i4Smsdy3RfpuLaEy9N3MRRHAftNiXOJA5Fp8WMKdpKe6hIjxp-8J7tJi5ltS1U_GPYT5Hesj6Bjlj24NDZ1F7rwUHUPnljt-W-9SkM8jR70kgYB6EdFkmWk2nsksgrgsTNSeKTWe6dwcD3CidQcbbF3-YWL8n20ug5dNHsFxdAXhHOh5VR6iY3mDm2KsE0ga0c0bIqq0vo76J0tRt9DUfNsPFS6mYfuvXXt7hB8VrzW3kqvw99eNY |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqYVJ34rb0mbtw5CtaWnd-kHb6d5G00UQZA5X8d_3Gjbd08hLyMHlAy53v0vuDuBBEE7fTMPSqEmEpltdrqEZwrWCULPDe5QQWb0hCKk31Z9nxqwGH9tYGJkn9EcmR0SJKlDeS3lfr_6dWEz-rVw_8ncc-nxyswFTN-hYpvsyVDYaOHHEIlu1bcRtaphIGqpOk-pDxEoHaGT3K3lwXkZVXMpqV6m4J3AYI79leQo1sWxCw97WXmvCUbB58sbuRvrWZ9BO42TcVfzQ80d-FiWpMgyZEjiZF7FUiVxlmjrn0HadzPY0nG3-t7n5a7S7NHIBdYT94hKUBY7zTqHnPYPr1LDMQtCuwJb3SV7kxRW09nG63k--h4aXBZP5xA_HN3BckSqPZc9oQb38-ha3qGpLfidP6Bfk3HvJ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SPRK1+INHIBITORS+AND+METHODS+OF+USE&rft.inventor=KUHN%2C+Cyrille&rft.inventor=LI%2C+Lianhai&rft.date=2024-07-25&rft.externalDBID=A1&rft.externalDocID=WO2024155864A1 |